BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials
BElumosudil for Bronchiolitis Obliterans Prevention/Therapy (BEBOP)
Conditions: Bronchiolitis Obliterans Syndrome; Bronchiolitis Obliterans; Lung Diseases; Chronic Graft Versus Host Disease Interventions: Drug: Belumosudil; Drug: Fluticasone; Drug: Azithromycin; Drug: Prednisone; Drug: Montelukast Sponsors: Dana-Farber Cancer Institute; Sanofi; National Heart, Lung, and Blood Institute (NHLBI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 28, 2023 Category: Research Source Type: clinical trials